Latest News & Updates
Breaking News
7 hours ago
Simantini Singh Deo
Other trending news you may like to read
Belite Bio Announces China NMPA Grants Priority Review For New Drug Application Of Tinlarebant In Stargardt Disease Based On Interim Analysis Results
China’s NMPA accepts Belite Bio’s Tinlarebant NDA for Stargardt disease with priority review, marking major progress.
Simantini Singh Deo
Novartis’ Fabhalta® (iptacopan) Achieves Phase III Primary Endpoint, Demonstrates Slowed Kidney Function Decline In IgA Nephropathy (IgAN) Patients
Novartis’ Fabhalta shows significant efficacy in slowing IgA nephropathy progression in Phase III APPLAUSE-IgAN study.
Simantini Singh Deo
Quercis Pharma And Thomas Lines Nominated For Prestigious Prix Galien USA “Best Startup” Award, Recognizing Innovation In Biopharma
Quercis Pharma and founder Thomas Lines nominated for the 2025 Prix Galien USA “Best Startup” Award for innovation in inflammasome-modulating therapies.
Simantini Singh Deo
FDA Grants Platform Technology Designation To Krystal Biotech’s HSV-1 Viral Vector Supporting KB801 For Neurotrophic Keratitis Treatment
FDA grants platform technology designation to Krystal Biotech’s HSV-1 viral vector used in its redosable gene therapy KB801.
Simantini Singh Deo
20251016105604.png)